Hubei Biocause Pharmaceutical Co., Ltd. - Current Ratio
000627.SZ
Price:
$1.58
Market Cap:
$7.75B
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its p...[Read more]
Industry
Insurance - Life
IPO Date
1996-11-12
Stock Exchange
SHZ
Ticker
000627.SZ
PE Ratio
[-10.53]
ROE
[-3.10%]
Current Ratio
[2.07]
Dividend Yield
[0%]
Enterprise Value
[5.01B]
Dividend History
The Current Ratio as of September 2026 (TTM) for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) is 2.07
According to Hubei Biocause Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.07. This represents a change of 6.36% compared to the average of 1.95 of the last 4 quarters.
Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) Historical Current Ratio (quarterly & annually)
How has 000627.SZ Current Ratio performed in the past?
The mean historical Current Ratio of Hubei Biocause Pharmaceutical Co., Ltd. over the last ten years is 2.89. The current 2.07 Current Ratio has changed 7.07% with respect to the historical average. Over the past ten years (40 quarters), 000627.SZ's Current Ratio was at its highest in in the March 2016 quarter at 21.07. The Current Ratio was at its lowest in in the September 2017 quarter at 0.19.
Average
2.89
Median
2.45
Minimum
0.68
Maximum
6.45
Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Hubei Biocause Pharmaceutical Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 552.23%
Maximum Annual Current Ratio = 6.45
Minimum Annual Increase = -48.50%
Minimum Annual Current Ratio = 0.68
| Year | Current Ratio | Change |
|---|---|---|
| 2023 | 2.07 | -7.55% |
| 2022 | 2.24 | -41.90% |
| 2021 | 3.86 | -40.26% |
| 2020 | 6.45 | 111.12% |
| 2019 | 3.06 | 62.54% |
| 2018 | 1.88 | -29.49% |
| 2017 | 2.67 | -48.50% |
| 2016 | 5.18 | 552.23% |
| 2015 | 0.79 | 16.42% |
| 2014 | 0.68 | 9.62% |
Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) Average Current Ratio
How has 000627.SZ Current Ratio performed in the past?
The current Current Ratio of Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.72
5-year avg
3.54
10-year avg
2.89
Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) Current Ratio vs. Peers
How is 000627.SZ’s Current Ratio compared to its peers?
Hubei Biocause Pharmaceutical Co., Ltd.’s Current Ratio is greater than Changjiang Securities Company Limited (1.26), greater than Jilin Aodong Pharmaceutical Group Co., Ltd. (1.65), greater than Guoyuan Securities Company Limited (0.61), greater than Tongling Nonferrous Metals Group Co.,Ltd. (1.44), greater than Hbis Company Limited (0.50),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.26 | $49.77B | |
| 1.65 | $21.77B | |
| 0.61 | $33.82B | |
| 1.44 | $87.16B | |
| 0.50 | $22.12B |
Build a custom stock screener for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hubei Biocause Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hubei Biocause Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Hubei Biocause Pharmaceutical Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
What is the highest Current Ratio for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
What is the 3-year average Current Ratio for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
What is the 5-year average Current Ratio for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
How does the current Current Ratio for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) compare to its historical average?